Volume 11, Number 12, December 2005

Central African Hunters Exposed to Simian Immunodeficiency Virus

Marcia L. Kalish,* Nathan D. Wolfe,† Clement B. Ndongmo,* Janet McNicholl,* Kenneth E. Robbins,* Michael Aidoo,* Peter N. Fonjungo,*‡ George Alemnji,‡ Clement Zeh,* Cyrille F. Djoko,§ Eitel Mpoudi-Ngole,‡ Donald S. Burke,† and Thomas M. Folks*
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; ‡Project IRECAM (Investigation of Retroviruses in Cameroon), Yaoundé, Cameroon; and §Johns Hopkins Cameroon Program, Yaoundé, Cameroon

Figure 1. Simian immunodeficiency (SIV) multiple antigenic peptide–enzyme immunoassay (SMAP-EIA) seroreactivity trends to SIV immunodominant region (IDR) peptides in HIV-seronegative Cameroonian population groups with different levels of exposure (high exposure [HE], low exposure [LE], or general [G]) to nonhuman primates. OD, optical density. χ² linear trend 48.166, p<0.001.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed November 4, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention